Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 73, Issue 7

Antifungal activity of propafenone on spp. strains: interaction with antifungals and possible mechanism of action No Access

Abstract

The development of new antifungal drugs has become a global priority, given the increasing cases of fungal diseases together with the rising resistance to available antifungal drugs. In this scenario, drug repositioning has emerged as an alternative for such development, with advantages such as reduced research time and costs.

Propafenone is an antiarrhythmic drug whose antifungal activity is poorly described, being a good candidate for further study.

This study aims to evaluate propafenone activity against different species of spp. to evaluate its combination with standard antifungals, as well as its possible action mechanism.

To this end, we carried out tests against strains of , , , , and based on the evaluation of the MIC, minimum fungicidal concentration and tolerance level, along with checkerboard and flow cytometry tests with clinical strains and cell structure analysis by scanning electron microscopy (SEM).

The results showed that propafenone has a 50% MIC ranging from 32 to 256 µg ml, with fungicidal activity and positive interactions with itraconazole in 83.3% of the strains evaluated. The effects of the treatments observed by SEM were extensive damage to the cell structure, while flow cytometry revealed the apoptotic potential of propafenone against spp.

Taken together, these results indicate that propafenone has the potential for repositioning as an antifungal drug.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antifungal , Candida spp. propafenone and repurposing drugs
© 2024 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001850
2024-07-09
2025-04-21
Loading full text...

Full text loading...

References

  1. Lockhart SR, Guarner J. Emerging and reemerging fungal infections. Semin Diagn Pathol 2019; 36:177–181 [View Article] [PubMed]
     [Google Scholar]
  2. Fatima Z, Kumari P, Rehman S, Hameed S. Virulence traits of Candida spp.: an overview. In Recent Trends in Mycological Research: Volume 1: Agricultural and Medical Perspective 2021 pp 439–455 [View Article]
     [Google Scholar]
  3. Pereira R, Dos Santos Fontenelle RO, de Brito EHS, de Morais SM. Biofilm of Candida albicans: formation, regulation and resistance. J Appl Microbiol 2021; 131:11–22 [View Article] [PubMed]
     [Google Scholar]
  4. Silva S, Negri M, Henriques M, Oliveira R, Williams DW et al. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol Rev 2012; 36:288–305 [View Article] [PubMed]
     [Google Scholar]
  5. Sikora A, Hashmi M, Zahra F. Candida auris; 2022 https://pubmed.ncbi.nlm.nih.gov/33085444/ accessed 19 December 2022
  6. OMS WHO fungal priority pathogens list to guide research, development and public health action; 2022 https://www.who.int/publications/i/item/9789240060241 accessed 19 December 2022
  7. Berdigaliyev N, Aljofan M. An overview of drug discovery and development. Future Med Chem 2020; 12:939–947 [View Article] [PubMed]
     [Google Scholar]
  8. Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 2004; 3:673–683 [View Article] [PubMed]
     [Google Scholar]
  9. Gurgel do Amaral Valente Sá L, da Silva CR, Neto JB de A, do Nascimento FBSA, Barroso FDD et al. Antifungal activity of etomidate against growing biofilms of fluconazole-resistant Candida spp. strains, binding to mannoproteins and molecular docking with the ALS3 protein. J Med Microbiol 2020; 69:1221–1227 [View Article] [PubMed]
     [Google Scholar]
  10. Rodrigues DS, Cabral VP de F, Barbosa AD, Sá LG do AV, Moreira LEA et al. Sertraline has in vitro activity against both mature and forming biofilms of different Candida species. J Med Microbiol 2023; 72: [View Article]
     [Google Scholar]
  11. Menezes EA, Vasconcelos Júnior AA de, Silva CLF, Plutarco FX, Cunha M da C dos SO et al. In vitro synergism of simvastatin and fluconazole against Candida species. Rev Inst Med Trop Sao Paulo 2012; 54:197–199 [View Article] [PubMed]
     [Google Scholar]
  12. Pina-Vaz C, Sansonetty F, Rodrigues AG, Martinez-DE-Oliveira J, Fonseca AF et al. Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species. J Med Microbiol 2000; 49:831–840 [View Article] [PubMed]
     [Google Scholar]
  13. Villanueva-Lozano H, Treviño-Rangel R de J, González GM, Hernández-Rodríguez PA, Camacho-Ortiz A et al. Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience. Infection 2018; 46:25–30 [View Article] [PubMed]
     [Google Scholar]
  14. Batista de Andrade Neto J, Alexandre Josino MA, Rocha da Silva C, de Sousa Campos R, Aires do Nascimento FBS et al. A mechanistic approach to the in-vitro resistance modulating effects of fluoxetine against meticillin resistant Staphylococcus aureus strains. Microb Pathog 2019; 127:335–340 [View Article] [PubMed]
     [Google Scholar]
  15. Das B, Mandal D, Dash SK, Chattopadhyay S, Tripathy S et al. Eugenol provokes ROS-mediated membrane damage-associated antibacterial activity against clinically isolated multidrug-resistant Staphylococcus aureus strains. Infect Dis 2016; 9:11–19 [View Article] [PubMed]
     [Google Scholar]
  16. Jorge P, Grzywacz D, Kamysz W, Lourenço A, Pereira MO. Searching for new strategies against biofilm infections: Colistin-AMP combinations against Pseudomonas aeruginosa and Staphylococcus aureus single- and double-species biofilms. PLoS One 2017; 12:e0174654 [View Article] [PubMed]
     [Google Scholar]
  17. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003; 52:1 [View Article] [PubMed]
     [Google Scholar]
  18. Neto JBA, da Silva CR, Neta MAS, Campos RS, Siebra JT et al. Antifungal activity of naphthoquinoidal compounds in vitro against fluconazole-resistant strains of different Candida species: a special emphasis on mechanisms of action on Candida tropicalis. PLoS One 2014; 9:e93698 [View Article] [PubMed]
     [Google Scholar]
  19. da Silva CR, de Andrade Neto JB, Sidrim JJC, Angelo MRF, Magalhães HIF et al. Synergistic effects of amiodarone and fluconazole on Candida tropicalis resistant to fluconazole. Antimicrob Agents Chemother 2013; 57:1691–1700 [View Article] [PubMed]
     [Google Scholar]
  20. Collins AR. The comet assay for DNA damage and repair: principles, applications, and limitations. Mol Biotechnol 2004; 26:249–261 [View Article] [PubMed]
     [Google Scholar]
  21. Miloshev G, Mihaylov I, Anachkova B. Application of the single cell gel electrophoresis on yeast cells. Mutat Res/Genet Toxicol Environ Mutagen 2002; 513:69–74 [View Article]
     [Google Scholar]
  22. Cavalcanti BC, de Andrade Neto JB, de Sousa Silva AA, Barreto FS, de Oliveira Ferreira JR et al. Evaluation of genotoxicity and mutagenicity of ketamine on human peripheral blood leukocytes and in Salmonella typhimurium. Toxicol In Vitro 2020; 62:104718 [View Article] [PubMed]
     [Google Scholar]
  23. de Andrade Neto JB, da Silva CR, Campos R de S, do Nascimento FBSA, Sampaio LS et al. Action mechanism of naphthofuranquinones against fluconazole-resistant Candida tropicalis strains evidenced by proteomic analysis: the role of increased endogenous ROS. Microb Pathog 2018; 117:32–42 [View Article] [PubMed]
     [Google Scholar]
  24. Farha MA, Brown ED. Drug repurposing for antimicrobial discovery. Nat Microbiol 2019; 4:565–577 [View Article] [PubMed]
     [Google Scholar]
  25. Kovacs B, Yakupoglu HY, Eriksson U, Krasniqi N, Duru F. Medical therapy with flecainide and propafenone in atrial fibrillation: long-term clinical experience in the tertiary care setting. Cardiol J 2023; 30:82–90 [View Article] [PubMed]
     [Google Scholar]
  26. Kruszewska H, Zaręba T, Kociszewska A, Tyski S. Activity of selected non-antibiotic medicinal preparations against standard microorganisms including bacterial probiotic strains. Acta Poloniae Pharmaceut - Drug Res 2021; 78:179–186 [View Article]
     [Google Scholar]
  27. Bagar T, Benčina M. Antiarrhythmic drug amiodarone displays antifungal activity, induces irregular calcium response and intracellular acidification of Aspergillus niger - amiodarone targets calcium and pH homeostasis of A. niger. Fungal Genet Biol 2012; 49:779–791 [View Article] [PubMed]
     [Google Scholar]
  28. Tyers M, Wright GD. Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat Rev Microbiol 2019; 17:141–155 [View Article]
     [Google Scholar]
  29. Ferreira GF, Baltazar L de M, Santos JRA, Monteiro AS, Fraga LA de O et al. The role of oxidative and nitrosative bursts caused by azoles and amphotericin B against the fungal pathogen Cryptococcus gattii. J Antimicrob Chemother 2013; 68:1801–1811 [View Article] [PubMed]
     [Google Scholar]
  30. Schuetzer-Muehlbauer M, Willinger B, Egner R, Ecker G, Kuchler K. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast. Int J Antimicrob Agents 2003; 22:291–300 [View Article] [PubMed]
     [Google Scholar]
  31. Ecker G, Chiba P, Hitzler M, Schmid D, Visser K et al. Structure-activity relationship studies on benzofuran analogs of propafenone-type modulators of tumor cell multidrug resistance. J Med Chem 1996; 39:4767–4774 [View Article] [PubMed]
     [Google Scholar]
  32. Kurzaątkowski W, Staniszewska M, Tyski S. Damage of Candida albicans blastoconidia exposed to biocides. Mycoses 2011; 54:e286-93 [View Article] [PubMed]
     [Google Scholar]
  33. Zheng W-B, Li Y-J, Wang Y, Yang J, Zheng C-C et al. Propafenone suppresses esophageal cancer proliferation through inducing mitochondrial dysfunction. Am J Cancer Res 2017; 7:2245–2256 [PubMed]
     [Google Scholar]
  34. Shao J, Feng G. Selective killing effect of oxytetracycline, propafenone and metamizole on A549 or Hela cells. Chin J Cancer Res 2013; 25:662–670 [View Article] [PubMed]
     [Google Scholar]
  35. de Andrade Neto JB, da Silva CR, Barroso FD, do Amaral Valente Sá LG, de Sousa Campos R et al. Synergistic effects of ketamine and azole derivatives on Candida spp. resistance to fluconazole. Future Microbiol 2020; 15:177–188 [View Article] [PubMed]
     [Google Scholar]
  36. Barroso FD, da Silva LJ, Sá LG, da Silva CR, Neto JB et al. Synergistic activity of dobutamine combined with azoles and its mechanism of action against strains of Candida glabrata. Future Microbiol 2022; 17:437–448 [View Article] [PubMed]
     [Google Scholar]
  37. Sikora A, Hashmi MF, Zahra F. Candida auris; 2024
/content/journal/jmm/10.1099/jmm.0.001850
Loading
Antifungal activity of propafenone on Candida spp. strains: interaction with antifungals and possible mechanism of action
J. Med. Microbiol. 73, 001850 (2024); https://doi.org/10.1099/jmm.0.001850
/content/journal/jmm/10.1099/jmm.0.001850
/content/journal/jmm/10.1099/jmm.0.001850
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error